Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.71 $1.96 Friday, 10th May 2024 SYBX stock ended at $1.79. This is 2.19% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 2.23% from a day low at $1.79 to a day high of $1.83.
90 days $1.55 $2.16
52 weeks $0.234 $5.71

Historical Synlogic Inc prices

Date Open High Low Close Volume
Jun 20, 2023 $0.561 $0.583 $0.540 $0.561 145 956
Jun 16, 2023 $0.550 $0.574 $0.523 $0.560 98 662
Jun 15, 2023 $0.550 $0.567 $0.544 $0.564 75 938
Jun 14, 2023 $0.551 $0.580 $0.549 $0.568 184 317
Jun 13, 2023 $0.590 $0.590 $0.550 $0.560 113 316
Jun 12, 2023 $0.590 $0.594 $0.550 $0.570 234 810
Jun 09, 2023 $0.580 $0.627 $0.570 $0.592 198 363
Jun 08, 2023 $0.580 $0.600 $0.570 $0.593 125 815
Jun 07, 2023 $0.606 $0.620 $0.560 $0.570 321 686
Jun 06, 2023 $0.533 $0.660 $0.525 $0.625 604 619
Jun 05, 2023 $0.560 $0.582 $0.485 $0.487 410 367
Jun 02, 2023 $0.550 $0.590 $0.535 $0.570 100 166
Jun 01, 2023 $0.540 $0.560 $0.531 $0.555 84 747
May 31, 2023 $0.553 $0.560 $0.525 $0.525 153 850
May 30, 2023 $0.570 $0.570 $0.537 $0.570 226 025
May 26, 2023 $0.552 $0.570 $0.545 $0.560 66 164
May 25, 2023 $0.553 $0.577 $0.530 $0.545 174 500
May 24, 2023 $0.558 $0.580 $0.542 $0.570 88 301
May 23, 2023 $0.550 $0.581 $0.550 $0.560 86 715
May 22, 2023 $0.566 $0.580 $0.547 $0.562 138 824
May 19, 2023 $0.580 $0.590 $0.530 $0.569 213 321
May 18, 2023 $0.550 $0.580 $0.550 $0.572 150 415
May 17, 2023 $0.530 $0.570 $0.530 $0.564 151 211
May 16, 2023 $0.555 $0.560 $0.531 $0.539 141 978
May 15, 2023 $0.590 $0.590 $0.540 $0.550 271 267
Click to get the best stock tips daily for free!

About Synlogic Inc

Synlogic Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase II clinical trials to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed... SYBX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT